Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Current Assets (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Current Assets for 5 consecutive years, with $21.6 million as the latest value for Q3 2020.

  • On a quarterly basis, Current Assets fell 63.7% to $21.6 million in Q3 2020 year-over-year; TTM through Sep 2020 was $21.6 million, a 63.7% decrease, with the full-year FY2019 number at $7.5 million, down 92.32% from a year prior.
  • Current Assets was $21.6 million for Q3 2020 at Forte Biosciences, down from $28.1 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $109.6 million in Q2 2017 to a low of $7.5 million in Q4 2019.
  • A 5-year average of $62.0 million and a median of $75.0 million in 2018 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: soared 179.19% in 2017, then tumbled 92.32% in 2019.
  • Forte Biosciences' Current Assets stood at $32.5 million in 2016, then skyrocketed by 179.19% to $90.6 million in 2017, then increased by 7.86% to $97.7 million in 2018, then crashed by 92.32% to $7.5 million in 2019, then skyrocketed by 188.0% to $21.6 million in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Current Assets are $21.6 million (Q3 2020), $28.1 million (Q2 2020), and $14.5 million (Q1 2020).